Phase I study of <scp>OPB</scp>‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
Michinori Ogura(Japanese Red Cross Nagoya Daini Hospital), Kiyohiko Hatake(International University of Health and Welfare)
Cited by 101
Related Papers
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149